UnitedHealth Group Inc (NYSE:UNH) CEO Steven H. Nelson sold 14,233 shares of UnitedHealth Group stock in a transaction on Thursday, March 15th. The shares were sold at an average price of $230.22, for a total value of $3,276,721.26. Following the transaction, the chief executive officer now directly owns 18,219 shares of the company’s stock, valued at $4,194,378.18. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.
Shares of UnitedHealth Group stock traded down $2.81 during mid-day trading on Monday, reaching $225.05. The company had a trading volume of 3,407,162 shares, compared to its average volume of 3,912,447. The company has a debt-to-equity ratio of 0.58, a quick ratio of 0.73 and a current ratio of 0.73. The firm has a market capitalization of $220,491.67, a price-to-earnings ratio of 21.01, a price-to-earnings-growth ratio of 1.33 and a beta of 0.74. UnitedHealth Group Inc has a 1 year low of $162.74 and a 1 year high of $250.79.
UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, January 16th. The healthcare conglomerate reported $2.59 EPS for the quarter, topping the Zacks’ consensus estimate of $2.50 by $0.09. The firm had revenue of $52.06 billion during the quarter, compared to analyst estimates of $51.57 billion. UnitedHealth Group had a return on equity of 21.29% and a net margin of 5.25%. The company’s revenue was up 9.5% on a year-over-year basis. During the same period last year, the company earned $2.11 earnings per share. analysts expect that UnitedHealth Group Inc will post 12.51 EPS for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 20th. Investors of record on Friday, March 9th will be given a $0.75 dividend. The ex-dividend date of this dividend is Thursday, March 8th. This represents a $3.00 dividend on an annualized basis and a yield of 1.33%. UnitedHealth Group’s payout ratio is 28.01%.
A number of research firms recently issued reports on UNH. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $225.00 price target on shares of UnitedHealth Group in a report on Monday, November 27th. Jefferies Group reaffirmed a “buy” rating and issued a $248.00 price target on shares of UnitedHealth Group in a report on Friday, December 1st. Raymond James Financial reaffirmed a “buy” rating on shares of UnitedHealth Group in a report on Wednesday, December 6th. Credit Suisse Group reaffirmed a “buy” rating on shares of UnitedHealth Group in a report on Wednesday, December 27th. Finally, Goldman Sachs began coverage on UnitedHealth Group in a report on Wednesday, January 3rd. They issued a “buy” rating and a $269.00 price target for the company. Two equities research analysts have rated the stock with a hold rating and twenty-six have given a buy rating to the company. UnitedHealth Group has an average rating of “Buy” and an average price target of $245.14.
A number of hedge funds have recently made changes to their positions in UNH. Capital International Investors grew its position in shares of UnitedHealth Group by 399.3% during the 3rd quarter. Capital International Investors now owns 4,132,602 shares of the healthcare conglomerate’s stock worth $809,370,000 after buying an additional 3,304,902 shares during the period. Jennison Associates LLC grew its position in shares of UnitedHealth Group by 146.0% during the 3rd quarter. Jennison Associates LLC now owns 5,541,977 shares of the healthcare conglomerate’s stock worth $1,085,396,000 after buying an additional 3,289,470 shares during the period. Janus Henderson Group PLC grew its position in shares of UnitedHealth Group by 1,820.1% during the 2nd quarter. Janus Henderson Group PLC now owns 2,388,641 shares of the healthcare conglomerate’s stock worth $442,896,000 after buying an additional 2,264,242 shares during the period. Egerton Capital UK LLP acquired a new position in shares of UnitedHealth Group during the 4th quarter worth about $368,905,000. Finally, Vanguard Group Inc. grew its position in shares of UnitedHealth Group by 2.5% during the 2nd quarter. Vanguard Group Inc. now owns 64,578,618 shares of the healthcare conglomerate’s stock worth $11,974,168,000 after buying an additional 1,588,516 shares during the period. Hedge funds and other institutional investors own 86.78% of the company’s stock.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.